Literature DB >> 29135835

Cardiovascular Disease and Type 2 Diabetes Risk Across Occupational Groups and Industry in a Statewide Study of an Australian Working Population.

Helen Louise Kelsall1, Palamandadige Harsha Suranga Fernando, Stella May Gwini, Malcolm Ross Sim.   

Abstract

OBJECTIVE: The aim of this study was to investigate prevalence of type 2 diabetes (diabetes) and cardiovascular disease (CVD) risk in occupational and industry groups in a large, diverse working population.
METHODS: Five hundred thousand Victorian workers undertook health checks, including lifestyle, anthropometric, and biomedical cardiovascular risk factor assessment. Five-year diabetes (AUSDRISK) and absolute CVD risk were estimated.
RESULTS: High diabetes and CVD risk was increased in many occupational groups and industries relative to managers and Professional/Scientific/Technical Services, respectively. Significantly more blue-collar workers had high diabetes risk [males prevalence ratio (PR) 1.19 (95% confidence interval, 95% CI 1.17 to 1.20); females 1.34 (95% CI 1.30 to 1.38)], high CVD risk [males 1.45 (95% CI 1.37 to 1.53); females 1.48 (95% CI 1.17 to 1.88], and risk factors including smoking [males 2.26 (95% CI 2.22 to 2.30); females 2.20 (95% CI 2.13 to 2.27)], compared with white-collar workers.
CONCLUSION: Targeting occupational and industry groups within sustainable workplace programs could assist in reducing chronic diseases, lowering sickness absence, and improving productivity.

Entities:  

Mesh:

Year:  2018        PMID: 29135835     DOI: 10.1097/JOM.0000000000001228

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  9 in total

1.  Observational study: handgrip strength, body composition and diabetes mellitus.

Authors:  Naomi Suda; Chrispin Manda; Joshua Gallagher; Yukiko Wagatsuma
Journal:  BMC Res Notes       Date:  2021-08-28

2.  Prevalence of Diagnosed Diabetes Among Employed US Adults by Demographic Characteristics and Occupation, 36 States, 2014 to 2018.

Authors:  Taylor M Shockey; Rebecca J Tsai; Pyone Cho
Journal:  J Occup Environ Med       Date:  2021-04-01       Impact factor: 2.306

3.  Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017.

Authors:  Thomas R Einarson; Annabel Acs; Craig Ludwig; Ulrik H Panton
Journal:  Cardiovasc Diabetol       Date:  2018-06-08       Impact factor: 9.951

4.  Prevalence of high cardiovascular risk by economic sector.

Authors:  Godelieve J M Vandersmissen; M Schouteden; C Verbeek; S Bulterys; L Godderis
Journal:  Int Arch Occup Environ Health       Date:  2019-07-15       Impact factor: 3.015

5.  Incidence and prevalence of type 2 diabetes by occupation: results from all Swedish employees.

Authors:  Sofia Carlsson; Tomas Andersson; Mats Talbäck; Maria Feychting
Journal:  Diabetologia       Date:  2019-09-17       Impact factor: 10.122

6.  Impact of Income and Industry on New-Onset Diabetes among Employees: A Retrospective Cohort Study.

Authors:  Reiko Ishihara; Akira Babazono; Ning Liu; Reiko Yamao
Journal:  Int J Environ Res Public Health       Date:  2022-01-19       Impact factor: 3.390

7.  Men's Health in Industries: Plastic Plant Pollution and Prevalence of Pre-diabetes and Type 2 Diabetes Mellitus.

Authors:  Sultan Ayoub Meo; Faris Jamal AlMutairi; Majed Mohammed Alasbali; Turki Badr Alqahtani; Saad Saeed AlMutairi; Rakan Abdulaziz Albuhayjan; Fawziah Al Rouq; Naseer Ahmed
Journal:  Am J Mens Health       Date:  2018-09-15

8.  Prevalence of Pre Diabetes and Type 2 Diabetes Mellitus among cement industry workers.

Authors:  Sultan Ayoub Meo; Yasser Abdullah Bin Muneif; Nasser Abdullah BenOmran; Mohammad Abdullah AlSadhan; Raed Fuad Hashem; Abdullah Saud Alobaisi
Journal:  Pak J Med Sci       Date:  2020 Jan-Feb       Impact factor: 1.088

9.  Mortality rates and cardiovascular disease burden in type 2 diabetes by occupation, results from all Swedish employees in 2002-2015.

Authors:  Sofia Carlsson; Tomas Andersson; Mats Talbäck; Maria Feychting
Journal:  Cardiovasc Diabetol       Date:  2021-06-26       Impact factor: 9.951

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.